Global Non Coding Rna Assays Market

Non Coding Rna Assays Comprehensive Study by Application (Oncological Applications, Biomarker Development, Infectious Medicine, Other Applications), End User (Research Laboratories, Biotechnology Academic Institutes, Others) Players and Region - Global Market Outlook to 2026

Non Coding Rna Assays Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Non Coding Rna Assays Market Overview:
For quantitative real-time PCR analysis of RNA expression, non-coding RNA assays are used. A pair of unlabeled PCR primers are used in non-coding RNA assays. The Non-coding RNA assay includes a dye-labeled taqman probe on the 5' end and a non-fluorescent quencher, also known as NFQ, on the 3' end. The TaqMan non-coding RNA assay is the only RNA assay on the market that can be used for RNA real-time PCR. The non-coding RNA assay is highly precise and straightforward to use. The accuracy, sensitivity, and other characteristics of non-coding RNA assays are among them. Non-coding RNA assays are very precise because they detect small fold changes with high quantitation precision.

Growth Drivers
  • Increasing Research and Developmental Activities
  • Rising Government Initiatives and Support for the Life Science Research Projects


Roadblocks
  • High Cost of Non-coding RNA Assays

Opportunities
  • Favorable Reimbursement for the Life Science and Biotech Research Projects
  • Availability of Different Equipment for Performing Research Activities

Challenges
  • Lack of Awareness


Competitive Landscape:

Some of the key players profiled in the report are Thermo Fisher Scientific (United States). Considering Market by End User, the sub-segment i.e. Research Laboratories will boost the Non Coding Rna Assays market.

Thermo Fisher Scientific Announces Next-Generation Transcriptome Profiling Assays for Fast Biomarker Discovery

What Can be Explored with the Non Coding Rna Assays Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Non Coding Rna Assays Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Non Coding Rna Assays
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Non Coding Rna Assays market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Non Coding Rna Assays market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Oncological Applications
  • Biomarker Development
  • Infectious Medicine
  • Other Applications
By End User
  • Research Laboratories
  • Biotechnology Academic Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Research and Developmental Activities
      • 3.2.2. Rising Government Initiatives and Support for the Life Science Research Projects
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Non Coding Rna Assays, by Application, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Non Coding Rna Assays (Value)
      • 5.2.1. Global Non Coding Rna Assays by: Application (Value)
        • 5.2.1.1. Oncological Applications
        • 5.2.1.2. Biomarker Development
        • 5.2.1.3. Infectious Medicine
        • 5.2.1.4. Other Applications
      • 5.2.2. Global Non Coding Rna Assays by: End User (Value)
        • 5.2.2.1. Research Laboratories
        • 5.2.2.2. Biotechnology Academic Institutes
        • 5.2.2.3. Others
      • 5.2.3. Global Non Coding Rna Assays Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Non Coding Rna Assays: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
  • 7. Global Non Coding Rna Assays Sale, by Application, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Non Coding Rna Assays (Value)
      • 7.2.1. Global Non Coding Rna Assays by: Application (Value)
        • 7.2.1.1. Oncological Applications
        • 7.2.1.2. Biomarker Development
        • 7.2.1.3. Infectious Medicine
        • 7.2.1.4. Other Applications
      • 7.2.2. Global Non Coding Rna Assays by: End User (Value)
        • 7.2.2.1. Research Laboratories
        • 7.2.2.2. Biotechnology Academic Institutes
        • 7.2.2.3. Others
      • 7.2.3. Global Non Coding Rna Assays Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Non Coding Rna Assays: by Application(USD Million)
  • Table 2. Non Coding Rna Assays Oncological Applications , by Region USD Million (2015-2020)
  • Table 3. Non Coding Rna Assays Biomarker Development , by Region USD Million (2015-2020)
  • Table 4. Non Coding Rna Assays Infectious Medicine , by Region USD Million (2015-2020)
  • Table 5. Non Coding Rna Assays Other Applications , by Region USD Million (2015-2020)
  • Table 6. Non Coding Rna Assays: by End User(USD Million)
  • Table 7. Non Coding Rna Assays Research Laboratories , by Region USD Million (2015-2020)
  • Table 8. Non Coding Rna Assays Biotechnology Academic Institutes , by Region USD Million (2015-2020)
  • Table 9. Non Coding Rna Assays Others , by Region USD Million (2015-2020)
  • Table 10. South America Non Coding Rna Assays, by Country USD Million (2015-2020)
  • Table 11. South America Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 12. South America Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 13. Brazil Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 14. Brazil Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 15. Argentina Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 16. Argentina Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 17. Rest of South America Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 18. Rest of South America Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 19. Asia Pacific Non Coding Rna Assays, by Country USD Million (2015-2020)
  • Table 20. Asia Pacific Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 21. Asia Pacific Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 22. China Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 23. China Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 24. Japan Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 25. Japan Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 26. India Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 27. India Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 28. South Korea Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 29. South Korea Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 30. Taiwan Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 31. Taiwan Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 32. Australia Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 33. Australia Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 36. Europe Non Coding Rna Assays, by Country USD Million (2015-2020)
  • Table 37. Europe Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 38. Europe Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 39. Germany Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 40. Germany Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 41. France Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 42. France Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 43. Italy Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 44. Italy Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 45. United Kingdom Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 46. United Kingdom Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 47. Netherlands Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 48. Netherlands Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 49. Rest of Europe Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 50. Rest of Europe Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 51. MEA Non Coding Rna Assays, by Country USD Million (2015-2020)
  • Table 52. MEA Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 53. MEA Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 54. Middle East Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 55. Middle East Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 56. Africa Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 57. Africa Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 58. North America Non Coding Rna Assays, by Country USD Million (2015-2020)
  • Table 59. North America Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 60. North America Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 61. United States Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 62. United States Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 63. Canada Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 64. Canada Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 65. Mexico Non Coding Rna Assays, by Application USD Million (2015-2020)
  • Table 66. Mexico Non Coding Rna Assays, by End User USD Million (2015-2020)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Non Coding Rna Assays: by Application(USD Million)
  • Table 69. Non Coding Rna Assays Oncological Applications , by Region USD Million (2021-2026)
  • Table 70. Non Coding Rna Assays Biomarker Development , by Region USD Million (2021-2026)
  • Table 71. Non Coding Rna Assays Infectious Medicine , by Region USD Million (2021-2026)
  • Table 72. Non Coding Rna Assays Other Applications , by Region USD Million (2021-2026)
  • Table 73. Non Coding Rna Assays: by End User(USD Million)
  • Table 74. Non Coding Rna Assays Research Laboratories , by Region USD Million (2021-2026)
  • Table 75. Non Coding Rna Assays Biotechnology Academic Institutes , by Region USD Million (2021-2026)
  • Table 76. Non Coding Rna Assays Others , by Region USD Million (2021-2026)
  • Table 77. South America Non Coding Rna Assays, by Country USD Million (2021-2026)
  • Table 78. South America Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 79. South America Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 80. Brazil Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 81. Brazil Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 82. Argentina Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 83. Argentina Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 84. Rest of South America Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 85. Rest of South America Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 86. Asia Pacific Non Coding Rna Assays, by Country USD Million (2021-2026)
  • Table 87. Asia Pacific Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 88. Asia Pacific Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 89. China Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 90. China Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 91. Japan Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 92. Japan Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 93. India Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 94. India Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 95. South Korea Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 96. South Korea Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 97. Taiwan Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 98. Taiwan Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 99. Australia Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 100. Australia Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 101. Rest of Asia-Pacific Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 102. Rest of Asia-Pacific Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 103. Europe Non Coding Rna Assays, by Country USD Million (2021-2026)
  • Table 104. Europe Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 105. Europe Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 106. Germany Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 107. Germany Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 108. France Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 109. France Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 110. Italy Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 111. Italy Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 112. United Kingdom Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 113. United Kingdom Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 114. Netherlands Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 115. Netherlands Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 116. Rest of Europe Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 117. Rest of Europe Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 118. MEA Non Coding Rna Assays, by Country USD Million (2021-2026)
  • Table 119. MEA Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 120. MEA Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 121. Middle East Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 122. Middle East Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 123. Africa Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 124. Africa Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 125. North America Non Coding Rna Assays, by Country USD Million (2021-2026)
  • Table 126. North America Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 127. North America Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 128. United States Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 129. United States Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 130. Canada Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 131. Canada Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 132. Mexico Non Coding Rna Assays, by Application USD Million (2021-2026)
  • Table 133. Mexico Non Coding Rna Assays, by End User USD Million (2021-2026)
  • Table 134. Research Programs/Design for This Report
  • Table 135. Key Data Information from Secondary Sources
  • Table 136. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Non Coding Rna Assays: by Application USD Million (2015-2020)
  • Figure 5. Global Non Coding Rna Assays: by End User USD Million (2015-2020)
  • Figure 6. South America Non Coding Rna Assays Share (%), by Country
  • Figure 7. Asia Pacific Non Coding Rna Assays Share (%), by Country
  • Figure 8. Europe Non Coding Rna Assays Share (%), by Country
  • Figure 9. MEA Non Coding Rna Assays Share (%), by Country
  • Figure 10. North America Non Coding Rna Assays Share (%), by Country
  • Figure 11. Global Non Coding Rna Assays share by Players 2020 (%)
  • Figure 12. BCG Matrix for key Companies
  • Figure 13. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 14. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 15. Global Non Coding Rna Assays: by Application USD Million (2021-2026)
  • Figure 16. Global Non Coding Rna Assays: by End User USD Million (2021-2026)
  • Figure 17. South America Non Coding Rna Assays Share (%), by Country
  • Figure 18. Asia Pacific Non Coding Rna Assays Share (%), by Country
  • Figure 19. Europe Non Coding Rna Assays Share (%), by Country
  • Figure 20. MEA Non Coding Rna Assays Share (%), by Country
  • Figure 21. North America Non Coding Rna Assays Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific (United States)
Select User Access Type

Key Highlights of Report


Apr 2021 250 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Non Coding Rna Assays Market Quantitative research analysis
Global Non Coding Rna Assays Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Non Coding Rna Assays Market Report?

Have a Query? Click Here

Other Related Reports

Rodent Surgery Services Comprehensive Study by Type (Aseptic Technique, Survival Surgery, Major Survival Surgery, Multiple Survival Surgeries), Application (Hamsters, Gerbils, Guinea Pig, Mice, Rats)...
$ 3750
Video Microscope Comprehensive Study by Type (3D, 2D), Application (Academic Research Institute, Forensic and Pathology Laboratory, Other), Industry Verticals (Biopharmaceutical, Food and Beverage, M...
$ 3450
Glass Bioreactors Comprehensive Study by Application (Pharmaceutical, Biotechnology, Vaccine Development, Biological Research, Others), Components (Microbial Cultures, Cell Cultures, Batch, Others), ...
$ 3450
Flexible Biomanufacturing Platform Comprehensive Study by Type (Single-use Technology, Modular Environment, Advanced Process Automation, Standardization), Modality (Machine Flexibility, Material Hand...
$ 3350
Cell Ion Indicators Comprehensive Study by Type (Calcium Indicators, Sodium Indicators, Magnesium Indicators, Zinc Indicators, PH Indicators), Application (Drug Discovery, Cell Signaling Studies, Fun...
$ 3650
New Drug Research and Development Services Comprehensive Study by Drugs (Small-molecule drugs, Biologics drugs), Services (Chemistry Services, Biology Services), Therapeutic Areas (Oncology, Infectio...
$ 3800